Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,735,596
+$385,535 QoQ
Shares Held
26,885
+1.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#558
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $175,268,765 across 14 Drug Manufacturers - General names. AMGN ranks #8 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
32,277 | $38,714,004 | |
| 2 | JNJ |
Johnson & Johnson
|
114,657 | $29,119,437 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
320,925 | $18,491,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
140,968 | $18,114,387 | |
| 5 | ABBV |
AbbVie Inc.
|
65,660 | $16,522,681 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
104,200 | $13,164,627 | |
| 7 | PFE |
Pfizer Inc
|
411,666 | $9,912,916 | |
| 8 | AMGN |
Amgen Inc
This page
|
26,885 | $9,735,596 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,735,596 | 26,885 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $9,350,061 | 26,574 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $8,784,018 | 26,837 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,141,236 | 21,762 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $4,935,315 | 17,676 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,780,347 | 12,134 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $996,426 | 3,823 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,265,963 | 3,929 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,160,439 | 3,714 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $943,373 | 3,318 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $947,297 | 3,289 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $890,133 | 3,312 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $596,567 | 2,687 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $650,307 | 2,690 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $674,984 | 2,570 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $593,929 | 2,635 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $586,353 | 2,410 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $621,719 | 2,571 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $758,598 | 3,372 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $692,175 | 3,255 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,477,612 | 6,062 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $487,418 | 1,959 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $253,831 | 1,104 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $115,896 | 456 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $107,552 | 456 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $86,362 | 426 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||